< Back to situations

[ORGANIZATION]

National Cancer Institute in Milan

Featured in 1 tracked story · first seen

Situations

[ACTIVE] [BUSINESS] [US] [CN] [ES]

Moderna and Merck melanoma vaccine clinical trials

16 clusters · 450 sources · last updated

Latest: Moderna expands cancer therapy ties and benefits from vaccine program news

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon